While the results beat expectations, investors were disappointed by the outlook for the next quarter, and the stock fell 30% in the aftermarket. This is one of the largest positions in my portfolio, so I'll definitely be overbought today.
I have a few stocks in my portfolio and the drop is horribly exaggerated. Everyone is panicking, but the business hasn't changed and the results have been good.
This $GOOG stock news is available only to Bulios Black members.
🛡️ Quarterly results of European armourer below estimates, but outlook remains strong! German armour, ammunition and military systems manufacturer Rheinmetall $RHM.DE has published Q2 results that fell short of market expectations, with sales of €2.43bn(vs. estimated 2.53 billion). and operating profit was EUR 276 million. (estimated EUR 283 million).
I am quite sorry and annoyed that this sector is not represented in my portfolio. It would take a bigger correction or I will look for more growth stocks in the arms sector.
This positive $WBD stock news is available only to Bulios Black members.
Shares of $AAPL rose 5% yesterday on news that Apple is investing an additional $100 billion in the US. I have sold $AAPL stock this year and moved my money into $GOOG and $AMZN. Apple no longer strikes me as an interesting company and growth is slowing.
🎬 Disney surprises with steady growth! In the third quarter of fiscal year 2025, Disney $DIS proved solid results. The company reported year-over-year revenue growth of 2 % to $23.65 billion, with net earnings per share (EPS) rose to $2.92, more than double last year's figure. Adjusted EPS was $1.61, up 16 % up 16% from last year.
I had the shares but eventually sold them and moved the money elsewhere. The performance hasn't been ideal and overall I don't find the sector interesting anymore.
This positive $DIS stock news is available only to Bulios Black members.
Pfizer ended up reporting pretty good results, and the stock is up 5%. The company is doing well, but I think it's all about whether they can develop a "miracle" drug. I still hold a few shares, but I'll probably sell the rest next year.
Will anyone be buying shares of $TTDtoday ?
While the results beat expectations, investors were disappointed by the outlook for the next quarter, and the stock fell 30% in the aftermarket. This is one of the largest positions in my portfolio, so I'll definitely be overbought today.
Zobrazit další komentáře
I have a few stocks in my portfolio and the drop is horribly exaggerated. Everyone is panicking, but the business hasn't changed and the results have been good.
Bitcoin miner with near-zero debt, AI ambitions and 70% growth in the last month
General Motors | Q2 2025: profit drop, tariff pressure and confidence in the second half of the year
American Eagle: The viral campaign, the Trump effect and the 23% rally - opportunity or trap?
🛡️ Quarterly results of European armourer below estimates, but outlook remains strong!
German armour, ammunition and military systems manufacturer Rheinmetall $RHM.DE has published Q2 results that fell short of market expectations, with sales of €2.43bn (vs. estimated 2.53 billion). and operating profit was EUR 276 million. (estimated EUR 283 million).
The shares react by falling...
Read more
Zobrazit další komentáře
I am quite sorry and annoyed that this sector is not represented in my portfolio. It would take a bigger correction or I will look for more growth stocks in the arms sector.
Shares of $AAPL rose 5% yesterday on news that Apple is investing an additional $100 billion in the US. I have sold $AAPL stock this year and moved my money into $GOOG and $AMZN. Apple no longer strikes me as an interesting company and growth is slowing.
Do you still consider $AAPL a growth stock?
Zobrazit další komentáře
There are certainly more interesting positions now. $AAPL isn't exactly cheap right now, so I've been buying up $AMD and $GOOG.
Philip Morris International | Q2 2025: transformation in full force
🎬 Disney surprises with steady growth!
...In the third quarter of fiscal year 2025, Disney $DIS proved solid results. The company reported year-over-year revenue growth of 2 % to $23.65 billion, with net earnings per share (EPS) rose to $2.92, more than double last year's figure. Adjusted EPS was $1.61, up 16 % up 16% from last year.
Read more
Zobrazit další komentáře
I had the shares but eventually sold them and moved the money elsewhere. The performance hasn't been ideal and overall I don't find the sector interesting anymore.
Pfizer ended up reporting pretty good results, and the stock is up 5%. The company is doing well, but I think it's all about whether they can develop a "miracle" drug. I still hold a few shares, but I'll probably sell the rest next year.
What do you think of $PFE?
Zobrazit další komentáře
I don't have any shares in my portfolio and probably won't buy any. This sector is very complex and also the $NVO thing is more interesting right now.